Satsuma Pharmaceuticals, Inc. Shares Authorized
Satsuma Pharmaceuticals, Inc. had Shares Authorized of 300.00 million shares as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2023-05-11
- 2023-03-31: Common Stock, Shares Authorized 300.00M shares.
- 2022-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2022-09-30: Common Stock, Shares Authorized 300.00M shares.
- 2022-06-30: Common Stock, Shares Authorized 300.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2023-03-31 | 300.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 300.00M shares 10-Q · filed 2023-05-11 |
| 2022-09-30 | 300.00M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 300.00M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 300.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 300.00M shares 10-K · filed 2023-03-28 |
| 2021-09-30 | 300.00M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 300.00M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 300.00M shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 300.00M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 300.00M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 300.00M shares 10-Q · filed 2020-08-11 |
| 2020-03-31 | 300.00M shares 10-Q · filed 2020-05-12 |
| 2019-12-31 | 300.00M shares 10-K · filed 2021-03-25 |
| 2019-09-30 | 300.00M shares 10-Q · filed 2019-11-12 |
| 2018-12-31 | 5.32M shares 10-K · filed 2020-03-10 |